Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Tel Aviv
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Therapeutics

Pluristem Therapeutics Inc

+ Add to Watchlist

PSTI:IT

1,131.00 ILs 39.00 3.33%

As of 09:24:40 ET on 05/23/2013.

Company Profile for Pluristem Therapeutics Inc (PSTI)

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Contact Information

Pluristem Therapeutics Inc

Matam Advanced Technology Park
Building 20
Haifa, 31905
Israel
Phone: 972-74-710-7171

Key Executives for Pluristem Therapeutics Inc (PSTI)

Zami AbermanChairman/President/CEOYaky YanayExec VP/CFO/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil